Stay updated on MOST: Stroke Thrombolysis Clinical Trial
Sign up to get notified when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.

Latest updates to the MOST: Stroke Thrombolysis Clinical Trial page
- CheckyesterdayChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked, replacing the usual content. The error page includes a Home link and a revision notice, signaling a site access issue rather than updated study information.SummaryDifference19%

- Check44 days agoChange DetectedThe page revision label changed from v3.6.5 to v3.6.6, indicating a small internal update to the page version. This change does not affect substantive study information or displayed details.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded access to the MOST study's Statistical Analysis Plan and Study Protocol, and updated information about IPD sharing and drug/regulatory details, reflecting the availability of key methodological documents and data-sharing options.SummaryDifference84%

- Check65 days agoChange DetectedThe page revision label was updated to Revision: v3.6.5, replacing the previous v3.6.4. This indicates a site update without altering the study information or functionality on the page.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, reflecting a small page update. This appears to be a minor documentation/QA change rather than a modification to study content or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to MOST: Stroke Thrombolysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.